Anna Wald

Appointments and Affiliations
 
 
University of Washington
School of Medicine
Medicine
Professor
University of Washington
Virology Research Clinic
Medical Director
Fred Hutchinson Cancer Research Center
Vaccine and Infectious Diseases
Member
University of Washington
School of Medicine
Laboratory Medicine
Professor
University of Washington
School of Public Health and Community Medicine
Epidemiology
Professor
 Professional Headshot of Anna Wald

Mailing Address

Box 359928
University of Washington
Virology Research Clinic
Seattle, Washington 98104
United States

Contact

Phone: (206) 520-4340
Fax: (206) 520-4371
annawald@u.washington.edu

Degrees

M.P.H., University of Washington, Epidemiology, 1994.
M.D., Mount Sinai School of Medicine, New York, 1985.

Research Interests

Epidemiology, natural history, therapy, and prevention of genital herpes; Interactions between HSV and HIV. Epidemiology and natural history of HHV-8 infections.

Languages

(Reading, Writing, Speaking)

Polish: (Fluent, Fluent, Fluent)

Recent Publications

2013
Jing, L, Schiffer JT, Chong TM, Bruckner JJ, Davies HD, Felgner PL, Haas J, Wald A, Verjans GMGM, Koelle DM.  2013.  CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.. Journal of virology. 87(5):2617-27. Abstract
Perti, T, Saracino M, Baeten JM, Johnston C, Diem K, Ocbamichael N, Huang M-L, Selke S, Magaret A, Corey L et al..  2013.  High-Dose Valacyclovir Decreases Plasma HIV-1 RNA More Than Standard-Dose Acyclovir in Persons Coinfected with HIV-1 and HSV-2: A Randomized Crossover Trial.. Journal of acquired immune deficiency syndromes (1999). 63(2):201-8. Abstract
Lingappa, J, Thomas KK, Hughes JP, Baeten JM, Wald A, Farquhar C, de Bruyn G, Fife KH, Campbell MS, Kapiga S et al..  2013.  Partner characteristics predicting HIV-1 setpoint in sexually acquired HIV-1 among African seroconverters.. AIDS research and human retroviruses. 29(1):164-71. Abstract
Roxby, AC, Liu AY, Drake AL, Kiarie JN, Richardson B, Lohman-Payne BL, John-Stewart GC, Wald A, De Rosa S, Farquhar C.  2013.  T Cell Activation in HIV-1/Herpes Simplex Virus-2-Coinfected Kenyan Women Receiving Valacyclovir.. AIDS research and human retroviruses. 29(1):94-8. Abstract
Bernstein, DI, Bellamy AR, Hook EW, Levin MJ, Wald A, Ewell MG, Wolff PA, Deal CD, Heineman TC, Dubin G et al..  2013.  Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 56(3):344-51. Abstract
2012
Jackson, LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, Edupuganti S, Winokur P, Mulligan MJ, Keyserling HL et al..  2012.  Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons.. The Journal of infectious diseases. 206(6):811-20. Abstract
Moss, NJ, Magaret A, Laing KJ, Kask AS, Wang M, Mark KE, Schiffer JT, Wald A, Koelle DM.  2012.  Peripheral blood CD4 T-cell and pDC reactivity to HSV-2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.. Journal of virology. 86(18):9952-63. Abstract
de Bruyn, G, Magaret A, Baeten JM, Lingappa J, Ndase P, Celum C, Wald A, Wald A.  2012.  Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: Results of analyses from a multicenter randomized trial.. BMC infectious diseases. 12(1):277. Abstract
Peng, T, Zhu J, Phasouk K, Koelle DM, Wald A, Corey L.  2012.  An Effector Phenotype of CD8+ T Cells at the Junction Epithelium during Clinical Quiescence of Herpes Simplex Virus 2 Infection.. Journal of virology. 86(19):10587-96. Abstract
Green, ML, Leisenring W, Stachel D, Pergam SA, Sandmaier BM, Wald A, Corey L, Boeckh MJ.  2012.  Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(11):1687-99. Abstract
Lu, Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L et al..  2012.  Acyclovir achieves lower concentration in African HIV-seronegative, HSV-2 seropositive women compared to non-African populations.. Antimicrobial agents and chemotherapy. 56(5):2777-9. Abstract
Stanaway, JD, Wald A, Martin ET, Gottlieb SL, Magaret AS.  2012.  Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition.. Sexually transmitted diseases. 39(5):388-93. Abstract
Chen, WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, Wolff M, Kotloff KL.  2012.  Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.. Vaccine. 30(28):4240-4248. Abstract
Jacob, ST, Banura P, Baeten JM, Moore CC, Meya D, Nakiyingi L, Burke R, Horton CL, Iga B, Wald A et al..  2012.  The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: A prospective intervention study.. Critical care medicine. 40(7):2050-8. Abstract
Belshe, RB, Leone PA, Bernstein DI, Wald A, Levin MJ, Stapleton JT, Gorfinkel I, Morrow RAL, Ewell MG, Stokes-Riner A et al..  2012.  Efficacy results of a trial of a herpes simplex vaccine.. The New England journal of medicine. 366(1):34-43. Abstract
Baeten, JM, Reid SE, Delany-Moretlwe S, Hughes JP, Wang RS, Wilcox E, Limbada M, Akpomiemie G, Corey L, Wald A et al..  2012.  Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial.. Sexually transmitted diseases. 39(1):21-4. Abstract
Martin, ET, Kuypers J, Wald A, Englund JA.  2012.  Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children.. Influenza and other respiratory viruses. 6(1):71-7. Abstract
Johnston, C, Saracino M, Kuntz S, Magaret AS, Selke S, Huang M-L, Schiffer JT, Koelle DM, Corey L, Wald A.  2012.  Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.. Lancet. 379(9816):641-647. Abstract
Jing, L, Haas J, Chong TM, Bruckner JJ, Dann GC, Dong L, Marshak JO, McClurkan CL, Yamamoto TN, Bailer SM et al..  2012.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.. The Journal of clinical investigation. 122(2):654-673. Abstract
Hughes, JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, Kiarie J, Inambao M, Kilembe W, Farquhar C et al..  2012.  Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1-Serodiscordant Couples.. The Journal of infectious diseases. 205(3):358-365. Abstract
Drake, AL, Roxby AC, Ongecha-Owuor F, Kiarie J, John-Stewart G, Wald A, Richardson BA, Hitti J, Overbaugh J, Emery S et al..  2012.  Valacyclovir Suppressive Therapy Reduces Plasma and Breast Milk HIV-1 RNA Levels During Pregnancy and Postpartum: A Randomized Trial.. The Journal of infectious diseases. 205(3):366-75. Abstract
Delaney, S, Gardella C, Daruthayan C, Saracino M, Drolette L, Corey L, Wald A.  2012.  A prospective cohort study of partner testing for herpes simplex virus and sexual behavior during pregnancy.. The Journal of infectious diseases. 206(4):486-94. Abstract
Roxby, AC, Drake AL, Ongecha-Owuor F, Kiarie JN, Richardson B, Matemo DN, Overbaugh J, Emery S, John-Stewart GC, Wald A et al..  2012.  Effects of Valacyclovir on Markers of Disease Progression in Postpartum Women Co-Infected with HIV-1 and Herpes Simplex Virus-2.. PloS one. 7(6):e38622. Abstract
Drake, AL, Roxby AC, Kiarie J, Richardson BA, Wald A, John-Stewart G, Farquhar C.  2012.  Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial.. PloS one. 7(4):e34635. Abstract
Murnane, PM, Hughes JP, Celum C, Lingappa JR, Mugo N, Farquhar C, Kiarie J, Wald A, Baeten JM.  2012.  Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.. PloS one. 7(11):e51192. Abstract